CIK: 0001858703
申報總市值
US$3.7億
申報季度: 2026-03-31 · 持股檔數: 76
Blue Owl Capital Holdings LP在最新一期 13F 報告中揭露了 76 項持股，申報期為 2026-03-31，總持股市值約為 US$3.7億，季度換手率為 60.7%。
Blue Owl Capital Holdings LP 目前揭露的持股，Herfindahl 集中度指數為 0.063——換算下來相當於約 16 個等權重部位，明顯低於其實際揭露的 76 檔持股。這個落差顯示該機構的策略偏向集中在少數高信心部位，而非廣泛分散。
整體部位大小差異頗大（變異係數為 1.94），除了少數重倉部位外，還有許多規模較小的持股。
最新申報季度中，並未觀察到明顯偏向加碼既有大部位或大舉建立新部位的傾向。
目前產業板塊分類約涵蓋此投資組合揭露價值的 8%；其餘部分（例如未對應板塊的標的、選擇權或其他證券類型）尚未納入板塊分類範圍。
加碼 MPLT
+207.6% US$1470.6萬
減碼 OBDC
0.0% -US$349.7萬
減碼 SGMT
-73.2% -US$561.9萬
減碼 HLLY
+2.2% -US$411.8萬
減碼 CMPX
-15.1% -US$305.5萬
減碼 NCDL
0.0% -US$132.9萬
僅顯示前 75 大持股（共 76 檔）
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AKTS | Aktis Oncology INC | 股票-其他 | 15.20% | +15.20% | NEW | |
| 2 | LRMR | Larimar Therapeutics INC | 股票-其他 | 8.61% | +0.59% | +4.34% | |
| 3 | ✓ | Engene Holdings INC | 股票-其他 | 8.08% | -1.29% | +31.40% | |
| 4 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 7.33% | -1.49% | — | |
| 5 | CGEM | Cullinan Therapeutics INC | 股票-其他 | 7.29% | -0.22% | -18.77% | |
| 6 | OBDC | Blue Owl Capital CORP | 股票-金融 | 6.08% | -1.98% | — | |
| 7 | MPLT | Maplight Therapeutics INC | 股票-其他 | 5.49% | +3.72% | +207.57% | |
| 8 | CMPX | Compass Therapeutics INC | 股票-其他 | 4.18% | -1.56% | -15.14% | |
| 9 | CNTX | Context Therapeutics INC | 股票-其他 | 3.58% | +0.21% | -31.53% | |
| 10 | HLLY | Holley INC | 股票-其他 | 3.49% | -1.80% | +2.18% | |
| 11 | EYPT | Eyepoint INC | 股票-其他 | 3.16% | +0.95% | +132.45% | |
| 12 | CRVS | Corvus Pharmaceuticals INC | 股票-其他 | 2.14% | +2.14% | NEW | |
| 13 | CNDT | Conduent INC | 股票-其他 | 1.73% | -1.13% | +4.44% | |
| 14 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.70% | +0.19% | +42.33% | |
| 15 | AQST | Aquestive Therapeutics INC | 股票-其他 | 1.50% | +0.45% | +156.75% | |
| 16 | RYTM | Rhythm Pharmaceuticals INC | 股票-其他 | 1.44% | +1.44% | NEW | |
| 17 | ✓ | Compass Pathways PLC | 股票-其他 | 1.38% | +1.38% | NEW | |
| 18 | IMMX | Immix Biopharma INC | 股票-其他 | 1.34% | — | -44.48% | |
| 19 | IMA | Imagenebio INC | 股票-其他 | 1.29% | -0.46% | +16.45% | |
| 20 | CVEO | Civeo CORP | 股票-其他 | 1.28% | -1.34% | -51.29% | |
| 21 | LENZ | Lenz Therapeutics INC | 股票-其他 | 1.25% | +0.51% | +237.81% | |
| 22 | ELDN | Eledon Pharmaceuticals INC | 股票-其他 | 1.18% | +0.28% | -26.43% | |
| 23 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 1.16% | -0.63% | -40.28% | |
| 24 | OVID | Ovid Therapeutics INC | 股票-其他 | 1.14% | +1.14% | NEW | |
| 25 | PVLA | Palvella Therapeutics INC | 股票-其他 | 1.05% | -0.25% | -22.36% | |
| 26 | PLRX | Pliant Therapeutics INC | 股票-其他 | 1.01% | — | — | |
| 27 | STWD | Starwood Property Trust INC | 股票-房地產 | 0.73% | +0.73% | NEW | |
| 28 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.70% | -0.21% | — | |
| 29 | EVMN | Evommune INC | 股票-其他 | 0.62% | +0.62% | NEW | |
| 30 | DELL | Dell Technologies -c | 股票-科技 | 0.61% | -1.48% | -74.19% | |
| 31 | ✓ | Larimar Therapeutics INC | 股票-其他 | 0.51% | +0.51% | NEW | |
| 32 | ORIC | Oric Pharmaceuticals INC | 股票-其他 | 0.51% | -0.79% | -70.87% | |
| 33 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 0.47% | -1.80% | -73.16% | |
| 34 | WW | Ww International Inc-new | 股票-其他 | 0.35% | +0.35% | NEW | |
| 35 | ✓ | Engene Holdings INC | 股票-其他 | 0.35% | +0.32% | +1316.00% | |
| 36 | EPD | Enterprise Products Partners | 股票-能源 | 0.32% | — | — | |
| 37 | FLD | Fold Holdings INC | 股票-其他 | 0.30% | — | — | |
| 38 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.23% | +0.17% | — | |
| 39 | MRKR | Marker Therapeutics INC | 股票-其他 | 0.19% | — | — | |
| 40 | ✓ | Mineralys Therapeutics INC | 股票-其他 | 0.16% | +0.16% | NEW | |
| 41 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.14% | -0.37% | -63.47% | |
| 42 | ✓ | Compass Therapeutics INC | 股票-其他 | 0.13% | +0.13% | NEW | |
| 43 | BNAIW | Brand Engagement Netwo -cw27 | 股票-其他 | 0.11% | +0.08% | -38.86% | |
| 44 | CAH | Cardinal Health INC | 股票-醫療保健 | 0.10% | — | — | |
| 45 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.05% | — | -18.73% | |
| 46 | PIPR | Piper Sandler Cos | 股票-金融 | 0.05% | — | — | |
| 47 | ✓ | Alpha Modus Hldgs INC | 股票-其他 | 0.04% | — | — | |
| 48 | ET | Energy Transfer LP | 股票-能源 | 0.03% | — | — | |
| 49 | ✓ | 股票-其他 | 0.03% | — | — | ||
| 50 | CAI | Caris Life Sciences INC | 股票-其他 | 0.02% | — | — |
Q3 2026績效
+7.6%
近4個季度績效
+35.8%
根據可取得價格的持股（佔申報價值的71%）計算
| 季度 | 持股檔數 | 總市值 | 穩定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 76 | US$3.7億 | 61 | |
| 2025-12-31 | 82 | US$3.2億 | 52 | |
| 2025-09-30 | 75 | US$3.2億 | 59 | |
| 2025-06-30 | 73 | US$3.1億 | 0 | |
| 2025-03-31 | 74 | US$3.1億 | 0 | |
| 2024-12-31 | 80 | US$4.3億 | 0 | |
| 2024-09-30 | 141 | US$5.2億 | 0 | |
| 2024-06-30 | 43 | US$3.6億 | 0 | |
| 2024-03-31 | 49 | US$5.0億 | 0 | |
| 2023-12-31 | 46 | US$4.2億 | 0 | |
| 2023-09-30 | 19 | US$1.3億 | 0 | |
| 2023-06-30 | 22 | US$1.6億 | 0 | |
| 2023-03-31 | 19 | US$1.6億 | 0 | |
| 2022-12-31 | 56 | US$2.4億 | 0 | |
| 2022-09-30 | 52 | US$2.3億 | 0 | |
| 2022-06-30 | 49 | US$2.0億 | 0 | |
| 2022-03-31 | 41 | US$2.3億 | 0 | |
| 2021-12-31 | 30 | US$18.9億 | 0 |
Blue Owl Capital Holdings LP 在 2026-03-31 最顯著的持倉異動： 新建倉: Aktis Oncology INC (AKTS); 清倉: Repare Therapeutics INC (RPTX); 新建倉: Corvus Pharmaceuticals INC (CRVS); 清倉: Procore Technologies INC (PCOR); 清倉: Roivant Sciences Ltd. (ROIV).
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | MPLT | Maplight Therapeutics INC | +3.7% | +207.57% | 加碼 |
| 2 | EYPT | Eyepoint INC | +1% | +132.45% | 加碼 |
| 3 | LRMR | Larimar Therapeutics INC | +0.6% | +4.34% | 加碼 |
| 4 | LENZ | Lenz Therapeutics INC | +0.5% | +237.81% | 加碼 |
| 5 | AQST | Aquestive Therapeutics INC | +0.5% | +156.75% | 加碼 |
| 6 | ✓ | Engene Holdings INC | +0.3% | +1316.00% | 加碼 |
| 7 | ELDN | Eledon Pharmaceuticals INC | +0.3% | -26.43% | 減碼 |
| 8 | CNTX | Context Therapeutics INC | +0.2% | -31.53% | 減碼 |
| 9 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +42.33% | 加碼 |
| 10 | OPTXW | Omnilit Acquisition Cl A -23 | +0.2% | — | 不變 |
| 11 | BNAIW | Brand Engagement Netwo -cw27 | +0.1% | -38.86% | 減碼 |
| 12 | ✓ | Adc Therapeutics SA | -0.2% | — | 不變 |
| 13 | CGEM | Cullinan Therapeutics INC | -0.2% | -18.77% | 減碼 |
| 14 | PVLA | Palvella Therapeutics INC | -0.3% | -22.36% | 減碼 |
| 15 | NIOBW | Niocorp Developments LTD -28 | -0.4% | -63.47% | 減碼 |
| 16 | IMA | Imagenebio INC | -0.5% | +16.45% | 加碼 |
| 17 | 4XC1 | Kalvista Pharmaceuticals INC | -0.6% | -40.28% | 減碼 |
| 18 | ORIC | Oric Pharmaceuticals INC | -0.8% | -70.87% | 減碼 |
| 19 | CNDT | Conduent INC | -1.1% | +4.44% | 加碼 |
| 20 | ✓ | Engene Holdings INC | -1.3% | +31.40% | 加碼 |
| 21 | CVEO | Civeo CORP | -1.3% | -51.29% | 減碼 |
| 22 | DELL | Dell Technologies -c | -1.5% | -74.19% | 減碼 |
| 23 | NCDL | Nuveen Churchill Direct Lend | -1.5% | — | 不變 |
| 24 | CMPX | Compass Therapeutics INC | -1.6% | -15.14% | 減碼 |
| 25 | SGMT | Sagimet Biosciences Inc-a | -1.8% | -73.16% | 減碼 |
| 26 | HLLY | Holley INC | -1.8% | +2.18% | 加碼 |
| 27 | OBDC | Blue Owl Capital CORP | -2% | — | 不變 |
| 28 | AKTS | Aktis Oncology INC | — | NEW | 新建倉 |
| 29 | RPTX | Repare Therapeutics INC | — | EXIT | 清倉 |
| 30 | CRVS | Corvus Pharmaceuticals INC | — | NEW | 新建倉 |
| 31 | PCOR | Procore Technologies INC | — | EXIT | 清倉 |
| 32 | ROIV | Roivant Sciences Ltd. | — | EXIT | 清倉 |
| 33 | RYTM | Rhythm Pharmaceuticals INC | — | NEW | 新建倉 |
| 34 | ✓ | Compass Pathways PLC | — | NEW | 新建倉 |
| 35 | IMRX | Immuneering CORP - Class A | — | EXIT | 清倉 |
| 36 | OVID | Ovid Therapeutics INC | — | NEW | 新建倉 |
| 37 | PAYO | Payoneer Global INC | — | EXIT | 清倉 |
| 38 | 260 | Centessa Pharmaceuticals-adr | — | EXIT | 清倉 |
| 39 | CMPS | Compass Pathways PLC | — | EXIT | 清倉 |
| 40 | NU | Nu Holdings Ltd. | — | EXIT | 清倉 |
| 41 | STWD | Starwood Property Trust INC | — | NEW | 新建倉 |
| 42 | MLYS | Mineralys Therapeutics INC | — | EXIT | 清倉 |
| 43 | EVMN | Evommune INC | — | NEW | 新建倉 |
| 44 | ✓ | Larimar Therapeutics INC | — | NEW | 新建倉 |
| 45 | JANX | Janux Therapeutics INC | — | EXIT | 清倉 |
| 46 | WW | Ww International Inc-new | — | NEW | 新建倉 |
| 47 | CHYM | Chime Financial Inc-cl A | — | EXIT | 清倉 |
| 48 | ✓ | Mineralys Therapeutics INC | — | NEW | 新建倉 |
| 49 | ✓ | Compass Therapeutics INC | — | NEW | 新建倉 |
| 50 | ✓ | Alpha Tau Medical LTD | — | EXIT | 清倉 |
| 季度 | 申報日期 | 類型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-20 | 修正案 | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-09 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-12 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-08-11 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-08-15 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-02-15 | 13F-HR | 在 EDGAR 上查看 |
| 2023-09-30 | 2023-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-06-30 | 2023-08-11 | 13F-HR | 在 EDGAR 上查看 |
| 2023-03-31 | 2023-05-11 | 13F-HR | 在 EDGAR 上查看 |
| 2022-12-31 | 2023-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2022-09-30 | 2022-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2022-06-30 | 2022-08-12 | 13F-HR | 在 EDGAR 上查看 |
| 2022-03-31 | 2022-05-16 | 13F-HR | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-05-16 | 修正案 | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-05-16 | 修正案 | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-02-11 | 13F-HR | 在 EDGAR 上查看 |
資產規模相近的機構
CIK 0001908619
申報總市值
US$3.7億
46 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001963404
申報總市值
US$3.7億
14 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001844375
申報總市值
US$3.7億
100 stks
2026-06-30
資產規模與本機構相差僅 0.0%
持倉風格相似的機構
CIK 0001687078
申報總市值
US$12.9億
41 stks
2026-03-31
前五大持倉重疊 2/5 檔，同樣重倉 Cullinan Therapeutics INC
CIK 0001791468
申報總市值
US$2.5億
28 stks
2023-09-30
資料過舊，未更新
前五大持倉重疊 1/5 檔，同樣重倉 Cullinan Therapeutics INC
CIK 0001910456
申報總市值
US$6.3億
23 stks
2026-03-31
前五大持倉重疊 1/5 檔，同樣重倉 Cullinan Therapeutics INC